中国病毒学论坛|我们一直在坚持!

标题: 疫苗学《Vaccines》——6th Edition by (美)普洛特金 [打印本页]

作者: rojjer    时间: 2015-7-25 14:07
标题: 疫苗学《Vaccines》——6th Edition by (美)普洛特金
! T. A: l3 U0 v! c% U2 Z
Vaccines, 6th Edition
- I2 r6 D5 q0 D. B8 a$ ~
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
/ h% i* J; W& G) E0 W( s: W8 f# w: q) G' Y, B9 }' f
http://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606
- n( ~4 k. R, M1 R
& \7 N" r& P9 o3 |6 lSECTION 1: General aspects of vaccination% G7 ?- a8 _7 i+ q1 m3 d/ M
1 A short history of vaccination 1) i9 h9 h3 \- I. x4 W
2 Vaccine immunology 14
/ [5 n" a& }& n; X3 V0 U9 w3 The vaccine industry 33
# M+ A* `$ u; t' z6 Q$ X/ Z4 Vaccine manufacturing 44# o+ X0 L& w/ w1 i1 |
5 Evolution of adjuvants across the centuries 58
. A1 W7 L0 n4 |* n$ n6 n% z$ a" b6 Vaccine additives and manufacturing residuals in the United States:" d: k$ ]2 g# f% V7 }; v$ L- j
licensed vaccines 71
1 q0 s- {8 e6 ]- h% D& Z7 Passive immunization 808 z/ i: R3 }' ]. \2 Q8 Q: i- w* n
8 General immunization practices 88
7 W* u) I8 u7 l$ eSECTION 2: Licensed vaccines, q: F0 I( n5 z6 |. x: U
9 Adenovirus vaccines 113# I% O+ v# k0 W, K2 X  z" o1 W4 i2 M
10 Anthrax vaccines 127
; M- D8 Q. B& d* G3 h& t* E11 Cholera vaccines 141
* B: w0 D* G- n12 Diphtheria toxoid 153
* o. `  u  D6 @5 [4 j13 Haemophilus influenzae vaccines 167
" b3 x/ `5 F& g4 c/ N/ k0 I9 H. Y0 ]14 Hepatitis A vaccines 183
# h% i* V$ V# Y9 y$ E15 Hepatitis B vaccines 205
6 x% D& \# w' Y16 Human papillomavirus vaccines 235
8 T. J1 r2 C' p5 S1 q17 Inactivated influenza vaccines 2572 _' J( f! z% Z7 J
18 Influenza vaccine-live 294
/ t  H3 G+ f' |& ~, h' k# b+ e19 Japanese encephalitis vaccines 312
3 b* ]; f- B- I$ G6 P: j! [; R20 Measles vaccines 352; _9 ^. q3 ]7 I7 s9 u% u* j
21 Meningococcal vaccines 388
" {3 t, H! _7 H* f22 Mumps vaccine 419
6 u* b2 D( A' U% e4 p23 Pertussis vaccines . 447
  A, r3 F7 @: S6 q$ Y* R  Y3 u( O" h24 Plague vaccines 493
) _4 Y! }: ?. O4 w: F, N+ I25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
5 r, |( m1 D+ Z! `0 R9 e; w26 Pneumococcal polysaccharide vaccines 542
2 ?" P  z& T- |1 @27 Poliovirus vaccine-inactivated . 573
4 m, ], t% Q& @* j. U" ?. X28 Poliovirus vaccine-live 598& W1 b# Q* h4 G- V' b0 u( }8 s* P
29 Rabies vaccines .646
/ x6 q- M# d  g" k$ D30 Rotavirus vaccines . 669
8 ?7 x! X+ `; }5 L31 Rubella vaccine 688
$ ]0 j% |5 o# }# P7 k6 ]32 Smallpox and vaccinia 718
+ _$ J5 c: h5 p! t$ y33 Tetanus toxoid 746
4 g6 Y, G  B# ?* O/ P% r34 Tick-borne encephalitis virus vaccines 773
8 d$ g, j3 [% i! ]4 P35 Tuberculosis vaccines 789! T/ M) ?: k# b. e* u5 q/ Y
36 Typhoid fever vaccines 812+ P" m! r" F& @9 r! O
37 Varicella vaccine 837
- f: n4 p) S& c+ y7 ?: S. M6 U1 E38 Yellow fever vaccine 870; d# \) G3 X) w! d- ?
39 Zoster vaccine 969& L6 S2 y% `9 W; y) b/ n3 I: _/ u- J
40 Combination vaccines 9816 e5 V, H& B: ^
SECTION 3: Vaccines in development and new vaccine strategies5 H8 H' h  S* {, F
41 Biodefense and special pathogen vaccines 10087 C0 ?- o# Z6 w/ x# m
42 Therapeutic cancer vaccines 10180 r) c3 U3 h% S9 {, A, f: q- r
43 Cytomegalovirus vaccines 1032
* l" a0 \' _3 [7 `3 O+ G, Z" p44 Dengue vaccines 10425 [9 e* y( H! i5 c2 a6 V1 T
45 Diarrhea caused by bacteria 1052/ m/ C, @, u5 i5 C6 t
46 Ebola vaccine 1060
3 a; D# z% C% B( u3 m47 Epstein-Barr virus vaccines 1068% G1 f" a  w. w$ r/ |: w) A
48 Hepatitis C vaccines 1074
, ?5 \& C: Q5 x3 W9 A5 Q6 D. ]49 Hepatitis E vaccines 1085
, U* c0 S2 C$ `7 ^' Q$ D50 Herpes simplex virus vaccines 1090. n' L$ o8 B0 {0 J
51 Human immunodeficiency virus vaccines 1097, A8 N2 w& ]- p
52 Lyme disease vaccines 1122
9 A, s1 n- P7 v0 p4 w53 Malaria vaccines 1133) r9 D' B* F. @- r1 C  O8 K
54 Noninfectious disease vaccines 1138
0 a) n# N' s5 i1 @8 A& _  E6 {! d- d55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
4 }3 S! L9 S5 N8 R# h  P5 @1 R56 Parasitic disease vaccines 1154
/ b  k8 b- [3 s; w( A6 a# U57 Staphylococcus aureus vaccines 1161% T2 @  o( w  ^: \
58 Streptococcus group A vaccines 11697 T& V* Z6 _! F" B# S  Y
59 Streptococcus group B vaccines 1176: \0 k* W7 w4 X! f. b
60 Technologies for making new vaccines 1182$ Z5 C0 c& D5 O
61 Alternative vaccine delivery methods 1200* ?' [* b+ f4 p) u/ s' ~! u
62 The development of gene-based vectors for immunization 12324 }, ]1 u+ R: `" u7 n  W  |
SECTION 4: Vaccination of special groups* P+ K$ {* l6 [6 ]9 y
63 Vaccination of immunocompromised hosts 1243: H8 Q- \8 S6 }3 {
64 Vaccination of human immunodeficiency virus-infected persons 12572 Y- Q' |4 O+ k0 K3 Y$ l
65 Vaccines for international travel 1270
# b+ }6 Y% j- c$ r- i) `7 N66 Vaccines for health care personnel 1290/ m* E+ m* M/ M
SECTION 5: Public health and regulatory issues
6 a$ A4 c. b% |) v; C) ~67 Immunization in the United States 1310
4 b" G, z1 l6 e$ T68 Immunization in Europe . 1334" _. A  e- P' f1 K9 R
69 Immunization in the Asia-Pacific region 13534 m7 X3 u& P; J$ }8 q; z
70 Immunization in developing countries 1369- F1 a( n5 P. i: L; c2 y# r
71 Community immunity 13958 ^9 d0 e4 m; e) O
72 Economic analyses of vaccine policies 1413
' H0 q. o9 \2 q; G5 [73 Regulation and testing of vaccines 1427
1 E/ |4 G4 D) r# m74 Regulation of vaccines in Europe 1447
4 u' G! K- P' q( f# y3 e6 O1 v3 p75 Regulation of vaccines in developing countries 1454/ U; M2 R0 v* Y7 S/ O
76 Vaccine safety 1464
8 X8 I; h' v& E+ ]77 Legal issues . 1481
2 x  X+ ]& Y; _4 V78 Ethics 1508
: ]: X/ N0 m8 j4 F8 w2 b) y5 c3 R

8 I6 n9 c, u$ ~  n, c
4 I  F! k4 I+ V# j; R
& W. v, K3 G; v: E. R; x! R

作者: salina    时间: 2015-7-26 14:55
非常感谢
作者: zhpu2008    时间: 2015-8-13 17:54
谢谢分享
作者: zhpu2008    时间: 2015-8-13 17:55
怎么看不到相关下载呀
作者: rojjer    时间: 2015-8-13 21:26

. o# T, N5 [# f- X/ B2 AVaccines, 6th Edition( Z/ t9 T3 y( A7 ^

: b; z1 H) J+ X+ C2 I" IApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
5 g0 e  [$ d, C" R( G9 W% [9 E# g3 S5 g/ X
http://yun.baidu.com/share/link? ... 1&uk=3810996606, M# u% R8 g0 G+ t1 H# ]- t( W" a

% u! P: G, S; QSECTION 1: General aspects of vaccination( x% T1 P) R# l8 w. V. O
1 A short history of vaccination 1
0 y9 x& O8 D; r3 @2 x2 Vaccine immunology 14
* E0 B3 b) {: m3 The vaccine industry 33; a8 {7 ^1 ~9 b
4 Vaccine manufacturing 44! P. y3 A9 u" A4 G4 N
5 Evolution of adjuvants across the centuries 58
, e1 l8 b) f; @0 S6 Vaccine additives and manufacturing residuals in the United States:. G; P, E$ t: b" s% o& [
licensed vaccines 718 h; ]0 q0 q" P- ?. y  {+ n
7 Passive immunization 80
  {# B2 j$ a7 u* _8 General immunization practices 88' L; r) K8 `) t
SECTION 2: Licensed vaccines
8 ~0 S2 y: x3 C7 ^/ ?$ ?5 G9 Adenovirus vaccines 113
' q* X4 j1 L9 i10 Anthrax vaccines 127  w9 v7 N* g% \* D/ L. \) N
11 Cholera vaccines 141
3 j  G: x6 d/ ^% Q# H7 N12 Diphtheria toxoid 153
- R2 Q" L; U* S1 M/ [13 Haemophilus influenzae vaccines 1670 X: ?. J4 Z6 T; I  ^
14 Hepatitis A vaccines 1832 E! X- b9 ?7 T
15 Hepatitis B vaccines 205
! M& F/ j" b5 u) R  a16 Human papillomavirus vaccines 235. C  x7 X( t; O
17 Inactivated influenza vaccines 2578 S/ x- }+ a+ d: L
18 Influenza vaccine-live 294
/ u. H( b9 h0 u19 Japanese encephalitis vaccines 312
/ ?( S8 U- [0 e2 [+ K/ F! H- D0 `1 m# H20 Measles vaccines 352
4 }( q; S- A% E& s21 Meningococcal vaccines 388- X$ _3 k1 F% }* J2 d
22 Mumps vaccine 419# T6 h) E3 z  E0 [0 x& B! j# m
23 Pertussis vaccines . 4478 j2 {6 C8 \" F
24 Plague vaccines 493
# f8 I7 a( T  k: L8 n. v5 @# ^25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
6 a+ w  p/ S  d! B2 \; B26 Pneumococcal polysaccharide vaccines 542& q) L$ ]& p4 z& D
27 Poliovirus vaccine-inactivated . 573* P$ A4 K8 S8 [5 m: j% C7 ~
28 Poliovirus vaccine-live 598
% N2 c: Z5 A4 W3 O29 Rabies vaccines .646
1 A! ^* ]1 y: m0 S30 Rotavirus vaccines . 669
% [+ S0 W3 k% i- i# D31 Rubella vaccine 688
* D* c9 ?, I4 R; L4 w- J7 A( x, G32 Smallpox and vaccinia 718
1 W5 J3 B* p- t# V; A33 Tetanus toxoid 746
7 V3 v- z. K2 H$ N6 A4 L; v: [34 Tick-borne encephalitis virus vaccines 7731 T4 Z! v! J6 p/ d( ?9 _. e
35 Tuberculosis vaccines 789
. @" l9 L5 x! u# j" u36 Typhoid fever vaccines 812
9 t2 M" W# |' {. J: f37 Varicella vaccine 837! x& {7 @, T+ l) o  d" |1 Q+ K# U
38 Yellow fever vaccine 8708 Z3 M( c# C& G9 v* k& E
39 Zoster vaccine 969
! ~: B" K& M& ^7 r$ E6 W# n40 Combination vaccines 981
# ]- {# K+ u: n' lSECTION 3: Vaccines in development and new vaccine strategies2 e6 e0 a( t; Z& A1 L
41 Biodefense and special pathogen vaccines 1008
* E; s/ B  g2 z# Q% _( d42 Therapeutic cancer vaccines 1018
3 k( n7 a, B. s. t% }4 f# W43 Cytomegalovirus vaccines 10326 j/ K0 D  w' |5 u0 b# j) u) f1 e
44 Dengue vaccines 1042- Q& E! g" ^! y. d  q! H$ y; D
45 Diarrhea caused by bacteria 1052  u, a" T8 g9 }( A
46 Ebola vaccine 1060
- p7 Q. V' j8 D  e  R47 Epstein-Barr virus vaccines 10680 Q7 U! q0 L/ F* ]6 I, V  ^
48 Hepatitis C vaccines 1074
  S) N# {# }8 |& B5 p1 Q49 Hepatitis E vaccines 1085
9 E* M1 y( e7 s! f0 w50 Herpes simplex virus vaccines 10905 C2 y8 `7 V3 }, K# M" m
51 Human immunodeficiency virus vaccines 1097
" f  Z4 E* f/ [3 v3 u52 Lyme disease vaccines 1122
  m, u9 m9 L+ G! E2 }" f53 Malaria vaccines 1133: [1 O4 I6 F3 z. ]* m
54 Noninfectious disease vaccines 1138% l3 n) v" H7 ~! A% z
55 Respiratory syncytial virus and parainfluenza virus vaccines 11467 b5 A8 m, B7 Z" J% Z
56 Parasitic disease vaccines 1154
) D& j/ {' l$ _  x3 N7 }. h# \- u57 Staphylococcus aureus vaccines 1161
; S& T7 ^8 v) a/ A+ q5 }58 Streptococcus group A vaccines 1169
+ G+ n- j, o" r" d59 Streptococcus group B vaccines 11768 s$ E' O! Z  e) S& K3 Z" j; R
60 Technologies for making new vaccines 1182% b; }7 G; T/ G% P
61 Alternative vaccine delivery methods 1200$ K8 A  D, t6 X: d
62 The development of gene-based vectors for immunization 12320 B* [+ W" A( B; \3 t5 a1 C1 F
SECTION 4: Vaccination of special groups- |1 w) z/ D# d9 B  j9 \
63 Vaccination of immunocompromised hosts 1243' C" ?1 W, }" x& K/ r
64 Vaccination of human immunodeficiency virus-infected persons 1257
1 B4 f$ z  x8 ~  ]! K. |65 Vaccines for international travel 12700 e' t0 S- f, d1 U0 h) T# E
66 Vaccines for health care personnel 1290
  f! l  G. l" w7 [$ {: RSECTION 5: Public health and regulatory issues6 Y5 u* B2 N2 g0 B4 Y8 q1 E
67 Immunization in the United States 1310
7 M$ o1 j+ A9 E+ Y! }$ u68 Immunization in Europe . 1334
8 `4 O* Y8 R( m4 ?( I, t69 Immunization in the Asia-Pacific region 1353
: x2 |! v6 x, O70 Immunization in developing countries 1369% l$ m, n* B' u: C8 I- F6 Y6 r
71 Community immunity 1395: r! U# e) N6 h/ n  T$ j  I8 \
72 Economic analyses of vaccine policies 1413
5 b; n( e/ @9 O& G8 L0 Q73 Regulation and testing of vaccines 1427
# i5 \, d5 n) H; y# ?/ @1 u4 X4 s74 Regulation of vaccines in Europe 1447
  E; D* K3 S: g. u( S5 G75 Regulation of vaccines in developing countries 1454
" V# @8 R; @% v' F, G/ t) g/ n76 Vaccine safety 1464
* }+ Y5 V8 D- u+ q& t  m1 j77 Legal issues . 1481
( c' Y# ]3 q" q* l' U78 Ethics 15083 z4 K2 c& O( Z0 G
' N; M% y& ~* N7 ]: O6 x
+ _3 \1 a4 |" h

作者: casarett    时间: 2017-5-2 15:25
Vaccines, 6e, 2012
/ ]$ ^, K0 z( _/ D- ^9 u6 A. `
1 w5 j, R  a& r0 u4 iHardcover: 1570 pages
9 ^1 \- F+ `2 ^) H7 o: \, [, qPublisher: Saunders; 6 edition (October 30, 2012)
/ ^$ r* w6 o0 ^. ^: G! m/ WLanguage: English* s; K# s2 f5 S0 A/ U4 u
ISBN-10: 1455700908" I) ^- }! _$ P$ a& J: H
Size: 52.3mb (original pdf): e4 y. K7 \0 [  O/ {/ c: C

7 E3 O* \# n, M6 g& x8 K, m/ Y2013 BMA Medical Book Awards Highly Commended in Public Health!
/ @5 n. }  V0 j, I9 R) cApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!
% C6 J) n0 Y; T. A; H) j
0 b6 c* n# d$ i# J4 y( zGain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.& s: D1 e  B2 s8 _' X% M
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
) V, D* J- c* T; t. z: x0 mGet complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.8 }, e* _) P0 }+ j# s  l! |
Analyze the cost-benefit and cost-effectiveness of different vaccine options.& ?! l2 ^' i# H
Clearly visualize concepts and objective data through an abundance of tables and figures.+ h: Q: A8 A& C( W- `: [, y
Perform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
; z) l* c6 T: Q  BMake optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.' \! p6 P% g$ C1 a6 P
Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.6 M' i" ]" n$ s

" }( o: y4 {/ x8 b$ n* ADownload link: http://pan.baidu.com/s/1i5NxwLR / k  S/ [6 D5 j, w$ K2 P/ H. k9 U
Code for downloading: dv96
, Q% J  R# o. C# C) F# w. f* N" c7 Q




欢迎光临 中国病毒学论坛|我们一直在坚持! (http://bbs.virology.com.cn/) Powered by Discuz! X3.2